DLL3 Antibody

Delta-like 3 is a protein which in humans is encoded by the DLL3 gene. This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutation in the mouse delta-like 3 gene, which is homologous to the Notch-ligand delta in Drosophila, results in the mouse 'pudgy' phenotype. The human gene was identified within a critical interval, mapped in two consanguineous Arab-Israeli and Pakistani SCDO1 pedigrees, of 7.8 cM at 19q13.1-q13.3 between D19S570 and D19S908 (Bulman et al., 2000) . Dunwoodie et al. (1997) presented results suggesting that mouse DLL3 may complement the function of other delta homologs during early pattern formation in the mouse embryo. In humans, the fact that mutations in genes required for oscillation, such as DLL3, result in abnormal segmentation of the vertebral column suggests that the segmentation clock also acts during human embryonic development. This residue is highly conserved in Delta proteins from Drosophila to humans, and the substitution of a charged polar for a nonpolar residue may disrupt the conformation of the DLL3 protein.

9007-83-4

Western blot: 0.5-1 µg/mL

Q9NYJ7

Human

Amino acids 599-618 (RAGQRQHLLFPYPSSILSVK-human) were used as the immunogen for this DLL3 antibody.

WB

Antigen affinity

Antigen affinity purified

Lyophilized from 1X PBS with 2.5% BSA and 0.025% sodium azide/thimerosal

After reconstitution, the DLL3 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

This DLL3 antibody is available for research use only.

After reconstitution, the DLL3 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.

0.5 mg/mL if reconstituted with 0.2ml sterile DI water

The stated application concentrations are suggested starting amounts. Titration of the DLL3 antibody may be required due to differences in protocols and secondary/substrate sensitivity.